Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo.
Saved in:
| Title: | Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo. |
|---|---|
| Authors: | Clerk A; School of Biological Sciences, University of Reading, Reading, U.K., Meijles DN; Molecular and Clinical Sciences Institute, St. George's University of London, London, U.K., Hardyman MA; School of Biological Sciences, University of Reading, Reading, U.K., Fuller SJ; School of Biological Sciences, University of Reading, Reading, U.K., Chothani SP; Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore Medical School, Singapore City, Singapore., Cull JJ; School of Biological Sciences, University of Reading, Reading, U.K., Cooper STE; Molecular and Clinical Sciences Institute, St. George's University of London, London, U.K., Alharbi HO; School of Biological Sciences, University of Reading, Reading, U.K., Vanezis K; National Heart and Lung Institute, Imperial College London, London, U.K.; MRC London Institute of Medical Sciences, Imperial College London, London, U.K., Felkin LE; National Heart and Lung Institute, Imperial College London, London, U.K.; Cardiovascular Research Centre, Royal Brompton and Harefield Hospitals, London, U.K., Markou T; School of Biological Sciences, University of Reading, Reading, U.K., Leonard SJ; School of Biological Sciences, University of Reading, Reading, U.K., Shaw SW; School of Biological Sciences, University of Reading, Reading, U.K., Rackham OJL; Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore Medical School, Singapore City, Singapore., Cook SA; Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore Medical School, Singapore City, Singapore.; MRC London Institute of Medical Sciences, Imperial College London, London, U.K.; National Heart Centre Singapore, Singapore City, Singapore., Glennon PE; University Hospitals Coventry and Warwickshire, University Hospital Cardiology Department, Clifford Bridge Road, Coventry, U.K., Sheppard MN; CRY Cardiovascular Pathology Department, St. George's Healthcare NHS Trust, London, U.K., Sembrat JC; Division of Pulmonary, Allergy and Critical Care Medicine, and Dorothy P & Richard P Simmons Center for Interstitial Lung Disease, Department of Medicine, University of Pittsburgh, Pittsburgh, U.S.A., Rojas M; Division of Pulmonary, Allergy and Critical Care Medicine, and Dorothy P & Richard P Simmons Center for Interstitial Lung Disease, Department of Medicine, University of Pittsburgh, Pittsburgh, U.S.A., McTiernan CF; Heart, Lung, Blood Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, U.S.A., Barton PJ; National Heart and Lung Institute, Imperial College London, London, U.K.; Cardiovascular Research Centre, Royal Brompton and Harefield Hospitals, London, U.K., Sugden PH; School of Biological Sciences, University of Reading, Reading, U.K. |
| Source: | The Biochemical journal [Biochem J] 2022 Feb 11; Vol. 479 (3), pp. 401-424. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Published by Portland Press on behalf of the Biochemical Society Country of Publication: England NLM ID: 2984726R Publication Model: Print Cited Medium: Internet ISSN: 1470-8728 (Electronic) Linking ISSN: 02646021 NLM ISO Abbreviation: Biochem J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35147166 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Clerk+A%22">Clerk A</searchLink>; School of Biological Sciences, University of Reading, Reading, U.K.<br /><searchLink fieldCode="AU" term="%22Meijles+DN%22">Meijles DN</searchLink>; Molecular and Clinical Sciences Institute, St. George's University of London, London, U.K.<br /><searchLink fieldCode="AU" term="%22Hardyman+MA%22">Hardyman MA</searchLink>; School of Biological Sciences, University of Reading, Reading, U.K.<br /><searchLink fieldCode="AU" term="%22Fuller+SJ%22">Fuller SJ</searchLink>; School of Biological Sciences, University of Reading, Reading, U.K.<br /><searchLink fieldCode="AU" term="%22Chothani+SP%22">Chothani SP</searchLink>; Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore Medical School, Singapore City, Singapore.<br /><searchLink fieldCode="AU" term="%22Cull+JJ%22">Cull JJ</searchLink>; School of Biological Sciences, University of Reading, Reading, U.K.<br /><searchLink fieldCode="AU" term="%22Cooper+STE%22">Cooper STE</searchLink>; Molecular and Clinical Sciences Institute, St. George's University of London, London, U.K.<br /><searchLink fieldCode="AU" term="%22Alharbi+HO%22">Alharbi HO</searchLink>; School of Biological Sciences, University of Reading, Reading, U.K.<br /><searchLink fieldCode="AU" term="%22Vanezis+K%22">Vanezis K</searchLink>; National Heart and Lung Institute, Imperial College London, London, U.K.; MRC London Institute of Medical Sciences, Imperial College London, London, U.K.<br /><searchLink fieldCode="AU" term="%22Felkin+LE%22">Felkin LE</searchLink>; National Heart and Lung Institute, Imperial College London, London, U.K.; Cardiovascular Research Centre, Royal Brompton and Harefield Hospitals, London, U.K.<br /><searchLink fieldCode="AU" term="%22Markou+T%22">Markou T</searchLink>; School of Biological Sciences, University of Reading, Reading, U.K.<br /><searchLink fieldCode="AU" term="%22Leonard+SJ%22">Leonard SJ</searchLink>; School of Biological Sciences, University of Reading, Reading, U.K.<br /><searchLink fieldCode="AU" term="%22Shaw+SW%22">Shaw SW</searchLink>; School of Biological Sciences, University of Reading, Reading, U.K.<br /><searchLink fieldCode="AU" term="%22Rackham+OJL%22">Rackham OJL</searchLink>; Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore Medical School, Singapore City, Singapore.<br /><searchLink fieldCode="AU" term="%22Cook+SA%22">Cook SA</searchLink>; Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore Medical School, Singapore City, Singapore.; MRC London Institute of Medical Sciences, Imperial College London, London, U.K.; National Heart Centre Singapore, Singapore City, Singapore.<br /><searchLink fieldCode="AU" term="%22Glennon+PE%22">Glennon PE</searchLink>; University Hospitals Coventry and Warwickshire, University Hospital Cardiology Department, Clifford Bridge Road, Coventry, U.K.<br /><searchLink fieldCode="AU" term="%22Sheppard+MN%22">Sheppard MN</searchLink>; CRY Cardiovascular Pathology Department, St. George's Healthcare NHS Trust, London, U.K.<br /><searchLink fieldCode="AU" term="%22Sembrat+JC%22">Sembrat JC</searchLink>; Division of Pulmonary, Allergy and Critical Care Medicine, and Dorothy P & Richard P Simmons Center for Interstitial Lung Disease, Department of Medicine, University of Pittsburgh, Pittsburgh, U.S.A.<br /><searchLink fieldCode="AU" term="%22Rojas+M%22">Rojas M</searchLink>; Division of Pulmonary, Allergy and Critical Care Medicine, and Dorothy P & Richard P Simmons Center for Interstitial Lung Disease, Department of Medicine, University of Pittsburgh, Pittsburgh, U.S.A.<br /><searchLink fieldCode="AU" term="%22McTiernan+CF%22">McTiernan CF</searchLink>; Heart, Lung, Blood Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, U.S.A.<br /><searchLink fieldCode="AU" term="%22Barton+PJ%22">Barton PJ</searchLink>; National Heart and Lung Institute, Imperial College London, London, U.K.; Cardiovascular Research Centre, Royal Brompton and Harefield Hospitals, London, U.K.<br /><searchLink fieldCode="AU" term="%22Sugden+PH%22">Sugden PH</searchLink>; School of Biological Sciences, University of Reading, Reading, U.K. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222984726R%22">The Biochemical journal</searchLink> [Biochem J] 2022 Feb 11; Vol. 479 (3), pp. 401-424. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Published+by+Portland+Press+on+behalf+of+the+Biochemical+Society%22">Published by Portland Press on behalf of the Biochemical Society </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2984726R <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1470-8728 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202646021%22">02646021 </searchLink><i>NLM ISO Abbreviation: </i>Biochem J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35147166 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1042/BCJ20210615 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 401 Titles: – TitleFull: Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Clerk A – PersonEntity: Name: NameFull: Meijles DN – PersonEntity: Name: NameFull: Hardyman MA – PersonEntity: Name: NameFull: Fuller SJ – PersonEntity: Name: NameFull: Chothani SP – PersonEntity: Name: NameFull: Cull JJ – PersonEntity: Name: NameFull: Cooper STE – PersonEntity: Name: NameFull: Alharbi HO – PersonEntity: Name: NameFull: Vanezis K – PersonEntity: Name: NameFull: Felkin LE – PersonEntity: Name: NameFull: Markou T – PersonEntity: Name: NameFull: Leonard SJ – PersonEntity: Name: NameFull: Shaw SW – PersonEntity: Name: NameFull: Rackham OJL – PersonEntity: Name: NameFull: Cook SA – PersonEntity: Name: NameFull: Glennon PE – PersonEntity: Name: NameFull: Sheppard MN – PersonEntity: Name: NameFull: Sembrat JC – PersonEntity: Name: NameFull: Rojas M – PersonEntity: Name: NameFull: McTiernan CF – PersonEntity: Name: NameFull: Barton PJ – PersonEntity: Name: NameFull: Sugden PH IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 02 Text: 2022 Feb 11 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1470-8728 Numbering: – Type: volume Value: 479 – Type: issue Value: 3 Titles: – TitleFull: The Biochemical journal Type: main |
| ResultId | 1 |